From: An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?
Characteristic | COX-2 Switchersa(N = 189) % | COX-2 Stoppersa (N = 81) % | χ2, df, p-value | |
---|---|---|---|---|
Continuous Rofecoxib User | 47 | 14 | 61.90, 1, < 0.0001 | |
Urban Area | 57 | 45 | 7.54, 1, 0.01 | |
Able to Manage on Income | 80 | 78 | 0.47, 1, 0.49 | |
No Formal Education | 72 | 73 | 0.03, 1, 0.87 | |
Marital | Married/De facto | 40 | 36 | Â |
 | Sep/Divorced | 4 | 6 | 2.29, 1, 0.32 |
 | Widowed/Single | 56 | 58 |  |
BMI | Underweight | 1 | 3 | Â |
 | Normal | 44 | 48 | 0.02b |
 | O/weight | 55 | 49 |  |
Alcohol | Non-drinker | 63 | 68 | Â |
 | Rarely/Low drinker | 32 | 31 | 0.05b |
 | Risky/High Risk | 5 | 1 |  |
Smoker | 4 | 5 | 0.77, 1, 0.38 | |
Excellent/Very Good/Good General Health | 63 | 59 | 0.60, 1, 0.44 | |
Consulted Family Doctor ≥5 Visits | 70 | 79 | 5.15, 1, 0.02 | |
Hospital Doctor Visit in 12 months | 19 | 26 | 3.36, 1, 0.07 | |
Specialist Doctor Visit in 12 months | 55 | 62 | 2.56, 1, 0.11 | |
Conditions: | Â | Â | Â | |
Ever Reported Arthritis | 86 | 77 | 9.03, 1, 0.003 | |
Hypertension | 61 | 54 | 2.93, 1, 0.09 | |
Depression | 6 | 8 | 1.29, 1, 0.26 | |
Anxiety/nervous | 7 | 7 | 0.15, 1, 0.70 | |
Asthma | 9 | 11 | 0.24, 1, 0.62 | |
Diabetes | 14 | 11 | 0.93, 1, 0.33 | |
Bronchitis/Emphysema | 5 | 9 | 3.3, 1, 0.07 | |
Heart Disease | 21 | 27 | 2.16, 1, 0.14 | |
Cancer | 4 | 6 | 1.97, 1, 0.16 |